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Biosynthetic and proliferative characteristics of tubulointerstitial fibro-
blasts probed with paracrine cytokines. Fibroblasts in parenchymal
organs potentially contribute extracellular matrix to local fibrogenic
processes. This contribution, in some circumstances, may be initiated
by cytokines disseminated from inflammatory lesions. Different popu-
lations of fibrobiasts, however, might respond distinctively to this
cytokine bath depending on the microenvironment in which they reside.
We have begun to explore this issue using syngeneic, low-passage
fibroblasts cultured in serum-free media that were derived originally
from the dermis (DFBs) and from tubulointerstitium (TFB5) of the
kidney. Our findings indicate that, while fibroblasts from each compart-
ment appear similar at the ultrastructural level, there are a variety of
functional differences which distinguish their proliferative response,
and their collagen secretory response (types I, III, IV, and V) following
challenge with various doses of immune-relevant cytokines (TGF/3,
EGF, IL-i, IL-2 and yIFN) in culture. DFB5, for example, express
more surface EGF receptors than do TFBs, and, as a consequence,
exhibit a more robust proliferative response to EGF in serum-free
media. Unstimulated DFBs also secrete more collagen types I and III
than TFBs, while unstimulated TFBs secrete more types IV and V. The
expression of these collagens in TFBs was confirmed by Northern blot
hybridization. When these sets of fibroblasts were further stimulated by
cytokines, some of the cytokines not only differentially effect the
secretion of various species of collagens within the same group of cells,
but also between cells from populations which are anatomically dis-
tinct. DFBs, furthermore, at mid-level doses of cytokine, demonstrated
a general trend towards less secretion of all types of collagen (particu-
larly for TGFf3, EGF, and IL-2), while TFBs seemed less repressive. In
TFBs the cytokine-induced responses for collagen types I and III
tended to be discordant, and for types I and IV EGF inhibited, while
TGFI3 stimulated the secretory process. These findings speak collec-
tively for the presence of a functional heterogeneity among organ-based
populations of syngeneic fibroblasts in normal tissues.
Fibrosis in parenchymal organs is the pernicious end-product
of progressive deposition of extracellular matrix remodelling
normal somatic architecture [1—31. Such damage is typically
preceded by inflammatory events which activate a variety of
tissue resident cells including fibroblasts [4, 51. The fibrogenesis
of organs, with its attendant distortion of normal structures, is
also frequently the late consequence of autoimmune injury
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[6—8]. It is thought that fibroblasts are probably responsive to
paracrine cytokines released by immune cells participating in
these local inflammatory events [9—13]. The anatomic microen-
vironment in which these fibroblasts reside, however, might
also selectively influence the extent to which such cells will
respond to this complexity of external signals. Various studies,
for example, have suggested that the comparison of homolo-
gous fibroblasts in one organ [14-18] or from different organs
[19—2 1] might demonstrate biologic evidence for functional
heterogeneity. Knowledge of such heterogeneity might predic-
tively assign relative responsibility for collagen secretion in
selected groups of cells inhabiting tissue-involved new fibro-
genic events.
Some of our previous work has focused on the cellular
mechanisms involved in the development of renal fibrogenesis
following autoimmune interstitial nephritis in rodents [1, 6, 9,
22]. In this report we have evaluated the hypothesis that the
proliferative response, and the secretion of structural collagens
following the addition of immune-relevant cytokines to cultures
of low-passage, syngeneic murine fibroblasts from the dermis
(DFBs) and tubulointerstitium (TFBs) may be influenced differ-
entially by the microenvironment from which these cells were
derived originally. Our findings suggest this hypothesis may be
correct.
Methods
Preparation of fibroblast cell lines
Kidneys were harvested from naive SJL/J mice (H-2°), the
cortices minced, and differentially sieved to isolate tubular-rich
interstitial fragments devoid of glomeruli (<1% glomeruli; cul-
tures of the glomeruli, parenthetically, did not produce fibro-
blast outgrowths on multiple attempts). The tubulointerstitial
fragments were diluted in DMEM with 20% FCS, 100 U/mi
penicillin, 100 rg/ml streptomycin, and 100 p.g/mi gentamycin,
and grown at 1 to 10 fragments/petri-dishes at 37°C in 5% CO2.
The media was changed weekly until a fibroblast monolayer
(TFBs) reached confluency [23]. In some early passage cultures
cloning rings or limiting dilution was used to isolate single cells
as cloned lines. Dermal fibroblasts (DFBs) were also obtained
from skin fragments placed under cover slips harvested from
naive SJL/J mice grown using the same conditions as the kidney
fibroblasts. Early passage fibroblasts from both organs were
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frozen in multiple aliquots, and all experiments were performed
with cells no older than 10 passages.
Electron microscopy studies
Monolayers of cells were fixed in situ in 3% glutaraldehyde in
0.1 M NaPO4 buffer with 0.026 M NaCI for three hours,
post-fixed in 1% 0s04 in 0.1 M NaPO4 for one hour, dehydrated
in graded ethanol solutions, and then embedded in EPON [24,
25]. Ultrathin sections were mounted on uncoated grids, stained
sequentially with lead citrate and uranyl acetate, and photo-
graphed on a Hitachi 600C electron microscope at 50 Ky [24].
Cytokines
Cytokines were added to serum-free cultures at varying
dilutions for biologic effect: recombinant murine y interferon
(yIFN; Dr. Michael Sheppard, Genetech, South San Francisco,
California, USA), recombinant murine interleukin-1 (IL-l; Dr.
Peter Lomedico, Roche Laboratories, Nutley, New Jersey,
USA), recombinant murine interleukin-2 (IL-2; Amgen, Thou-
sand Oaks, California, USA), recombinant transforming growth
factor p (TGFI3; R & D Systems, Minneapolis Minnesota,
USA), and recombinant epidermal growth factor (EGF; Bio-
medical Technologies, Cambridge, Massachusetts, USA).
Measurement of fibroblast proliferation
To begin, l0 cells/triplicate well were plated into 96-well
flat-bottom microtiter plates in DMEM with 10% FCS overnight
[6, 26]. The media was aspirated and washed twice with
serum-free DMEM supplemented with transferrin/insulin (TF/I;
5 jig/mI). After two to three days of incubation, the wells were
pulsed with 1 jiCilml 3HTdR for six hours. The media was
removed and the cells were trypsinized, harvested on to glass-
fiber filter paper, and counted for beta emissions in scintillation
fluid. Data were expressed as mean cpm SEM, or as a
proliferation index (experimental cpm/control cpm).
Radioimmunoassay of secreted co/la gens
For this, iO cells/triplicate well were plated in 96-well
flat-bottom microtiter plates and grown to confluency in DMEM
with 10% FCS [23, 25]. At that point the media was replaced
with DMEM containing TF/I (5 jig/ml), ascorbic acid (50
jig/ml), /3-aminopropionitrile (50 jig/ml), and various concentra-
tions of cytokines. The cells were incubated for an additional 48
to 72 hours, and then the supernatants were harvested, and
assayed for the secretion of soluble collagens by solid-phase
radioimmunoassay using primary antibodies to collagen types I,
III, IV, and V followed by a species-specific '251-labelled
secondary antibody [25]. Antibody binding to supernatants
were compared to standard curves, and the results were ex-
pressed in jig or nglml normalized for cell number. SEM for
repetitive collagen measurements varied by 5 to 15%.
Epidermal growth factor (EGF) receptor-binding studies
Fibroblast binding to 1251-labelled EGF was analyzed by
Scatchard analysis to determine apparent Kd and R0 [26].
Binding studies were conducted using confluent monolayers of
fibroblasts in 24 multiwell plates. Cells were seeded at a density
of 1 x l0 cells/well in 1.0 ml of culture medium and grown to
confluency (3 days). The binding reaction was carried out in 0.2
ml of Eagles Minimal Essential Medium containing 0.2% (wt/
vol) BSA and 25 mrvi HEPES, pH 7.4. The specific radioactivity
of the '251-EGF was adjusted to 3 mCi/jig by the addition of
non-labelled EGF, and the final concentration of EGF incu-
bated with cells ranged from 0.08 to 1.5 flM. Non-specific
binding was determined in the presence of a 1000-fold excess of
unlabelled EGF, and always was less than 10% of the total cell
bound radioactivity. After incubation for 90 minutes at 4°C, the
plates were drained and flooded three times with ice cold PBS
to remove unbound EGF. The cells in each well were then
dissolved in I ml of 10% NaOH for 10 minutes at room
temperature prior to determining their radioactivity.
Northern hybridizations
Total fibroblast RNA for Northern hybridizations was pre-
pared in guandinium isothiocyanate, and separated in 0.8%
agarose gels in 2.2 M formamide/formaldehyde [27, 28]. The gels
were transblotted on to Zetabind paper and hybridized in 7%
SDS containing ssDNA (300 jsg/ml), polyadenylic acid (300
p,g/ml), and 5 x SSPE. The blots were hybridized to 32P-labeled
probes labelled by hexamer priming [(SA = 0.5 to 1.0 X i0
cpmljig)1 representing either a 0.85 kb Xhol fragment of murine
type a2(1) collagen from pAZ1002 [291, a 1.8 kb EcoRI fragment
of murine al(III) collagen from pMCS-1 [29], a 0.66 kb Pstl
fragment of murine type cl(IV) collagen from pcl5 [301, or a
1.75 kb Pstl fragment of human a2(V) collagen from N3-6 [31].
The filters were washed for 15 minutes twice in 3x SSC, 0,5%
SDS at 26°C, and once in 0.1 x SSC, 0.5% SDS at 65°C for one
hour, and then autoradiographed with intensifying screens at
—70°C.
Results
Characterization of the fibroblast cell lines
Fibroblast cell lines from the tubulointerstitium (TFBs) and
skin (DFBs) were established as primary cultures from SJL
mice. This strain of inbred mouse was chosen so that our cells
would be syngeneic to the other immune and epithelial cell
reagents which we have prepared over the last several years in
our study of experimental interstitial nephritis [22, 25, 32].
Attempts to grow fibroblasts from isolated cortical glomeruli
were not successful, suggesting that they are not resident
normally in that compartment of the kidney.
In the current experiments we first wanted to determine if our
cells had attributes of fibroblasts, and to discern if there might
be any morphologic heterogeneity between fibroblasts from
different anatomic compartments. While immunofluorescent
staining of TFBs and DFBs revealed no reactivity with cyto-
keratin antibodies, there was positive staining for vimentin, and
actin, and light photomicrographs of both cell types demon-
strated the presence of spindle-like cytoplasmic extensions,
multi-lobed nuclei, several nucleoli, and many granules (data
not shown). Ultrastructural analysis of the cells revealed indis-
tinguishable features between DFBs (Fig. 1A) and TFBs (Fig.
1 B). They exhibited large amounts of rough endoplasmic retic-
ulum, characteristic of matrix-producing cells, and numerous
lysosomes, but showed no intercellular junctions or basal
lamina-like material. Collagen deposition could also be ob-
served between cells (Fig. lA, arrows). These findings suggest
collectively that our TFBs and DFBs cells have morphologic
characteristics similar to prototypical, generic fibroblasts [33,
34].
Comparison of proliferative responses between TFBs and
DFBs
We next examined the growth characteristics of these two
fibroblast populations in response to fetal calf serum (FCS),
serum-free (TF/I) media, and TF/I plus various immune-rele-
vant cytokines, including yIFN, TOF/3, and IL-2. All of these
latter cytokines are potential functional constituents of an
inflammatory milieu. We first compared TFBs and DFBs grown
in 10% serum or in serum-free (TF/I) culture. In Figure 2 (A and
B) both cell types increased in absolute numbers over the first
72 hours of culture when compared to TF/I (serum-free) condi-
tions. This real growth also mapped concordantly with in-
creases in 3HTdR incorporation expressed as a proliferation
index over the same time frame, and were consistent with
similar data obtained previously with guinea pig fibroblasts [22].
Subsequent fibroblast proliferation experiments were per-
formed between 48 and 72 hours.
Figure 3 (A and B) illustrates that TFBs incorporate more
absolute amounts of 3HTdR than DFBs when grown in the
presence of serum-free TF/I, but that both respond appropri-
ately to increasing concentrations of FCS. TFBs, by absolute
cpms, also incorporate more 3HTdR in response to increasing
amounts of TGF/3 and EGF than do DFBs (Fig. 4 A and B).
Both cell populations, however, do not proliferate in the
presence of IL-2 or 7IFN. When the background incorporations
of 3HTdR are normalized, by calculating a proliferation index
[61, the findings represented in Figure 4C better demonstrate
that neither fibroblast population grew in response to IL-2 or
7IFN, but that DFBs were relatively better respondents to
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Fig. 1. Ultrastructural features of DFBs (A)
and TFBs (B). Unstimulated monolayers were
fixed in situ, processed for electron
microscopy, sectioned longitudinally, stained
with lead citrate-uranyl acetate, and examined
with a Hitachi 600C electron microscope,
operated at 50 Ky. Nucleus (Nu); Lysosomes
(Ly). Arrows (A) indicate extracellular matrix
deposits, primarily collagen type I (3330x
original magnification).
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Fig. 2. Comparison offibroblast cell counts with 3HTdR incorporation
over time. (A) Replicate TFBs were passaged to 96-well flat-bottom
microtiter plates at iO cells/well and grown in either 10% serum (—•—)
or in TF/I (—U—) over 96 hours. Some replicate wells were hand counted
and co-plotted as a line graph using reference coordinates on the right
axis with a simultaneous proliferation index (3HTdR) plotted as a bar
graph using reference coordinates on the left axis. The proliferation
indices were determined from triplicate wells pulsed with 3HTdR for the
last 6 hours of each designated time interval expressed as serum
cpms/TF/I cpms. (B) Same as above using DFB cells. In both (A) and
(B) cells grown in serum, using these culture parameters, increased
incrementally over the first 72 hours by actual count or by 3HTcIR
incorporation.
TGF/3 and EGF than were TFBs. These two fibroblast popula-
tions, therefore, have different proliferative responses to cyto-
kine stimulation in serum-free media.
Comparison of EGF receptor-binding
We next performed Scatchard analyses to further examine
the above differences noted in the proliferative response of
TFBs and DFBs to EGF. Figure 5A and B demonstrates typical
Scatchard plots obtained with '251-EGF on confluent monolay-
ers of TFBs and DFBs. Binding analysis at 37°C demonstrated
that both TFBs and DFBs bound EGF with Kd of 0.3 and 0.4
flM, respectively. The relative R0 for each fibroblast culture
indicated, however, that TFBs expressed 17 x i03 receptor
sites while DFBs expressed 118 x iO receptor sites per cell.
These differences in receptor number are nevertheless in the
general range reported previously for other fibroblasts [35].
Fig. 3. Modulation of prol(feration of TFBs (A) and DFBs (B) in
response to TF/J (0%, 4%, 40%, and 100%) or FCS (0%, 5%, 10%, and
15%). Symbols are (U) %; (E) 4/5; (l) 20/10; () 100/15. Triplicate
wells were pulsed for 6 hours with 3HTdR at the end of a 48-hour
culture interval, counted for scintillations, and expressed a mean SEM
for three experiments.
Comparison of extracellular matrix secretion between TFBs
and DFBs
Many reports have demonstrated that fibroblasts can be a
major source of extracellular matrix [1]. To further determine
the extent of functional heterogeneity among anatomically
distinct fibroblast populations, we next examined the collagen
secretory profiles of both TFBs and DFBs cultured in the
presence of ascorbate and cross linking inhibitors. In Figure 6 it
can be observed that both fibroblast populations express colla-
gen types I, III, IV, and V. TFBs, however, produce more
collagen types IV and V than DFBs, while DFBs secrete
predominantly more collagen types I and III. Such differences
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FIg. 4. Modulation of proliferation of TFBs (A) and DFBs (B) in
response to various cytokines. Symbols for A and B are: (U) 0/0/010;
(0)10/0.04/0.4/1; (0)100/0.2/2.0/10; (0) 1000/l.0/1O.0/lO0. Triplicate
wells were pulsed for 6 hours with 3HTdR at the end of a 48-hour
culture in the presence of various concentrations of yIFN (0, 10, 100,
and 1000 U/ml).TGF (0, 0.04, 0.2, and 1 ng/ml), EGF (0, 0.4, 2, and 10
ng/ml), or IL-2 (0, 1, 10, and 100 U/mi), counted for scintillations, and
expressed a mean 5EM for three experiments. (C) Comparative
indices of proliferation were also made for normalized evaluation of
each cytokine: 7IFN (10 U/mI), TGFI3 (1 ng/ml), BOF (2 ng/ml), and
IL-2 (10 U/mI). Symbols are: () TFB; (0) DFB.
have been observed in multiple separate experiments (data not
shown). To additionally confirm the presence of all these
species of collagen in our cells, we performed Northern blot
hybridizations on total RNA harvested from TFBs using DNA
probes for types I, III, IV, and V collagens. This investigation
revealed the presence of mature transcripts, of predicted size,
for each of the collagen species (Fig. 7).
Since we have also been interested in paracrine cytokine
modulation of the biosynthesis of collagens in fibroblasts, we
further evaluated the influence of several immune-relevant
cytokines on collagen secretion in our two populations of cells.
This analysis was extended to the effects of various doses of
cytokines (IL- 1, IL-2, yIFN, TGF/3, and EGF) on the secretion
of types I, III, IV, and V collagens. In Figure 8 are selected
comparisons for each type of collagen to make a direct point
regarding the heterogeneity of potential responses between
TFBs and DFBs. Such responses seem to depend on the dose of
cytokine and the anatomic origin of the cells.
A large amount of similar data has also been summarized for
TFBs (Fig. 9) and DFBs (Fig. 10). The results in these latter two
figures are expressed as a comparative compilation reflecting a
percent change from control. At a given dose of cytokine,
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of io cells were grown to confluence and incubated with various
concentrations of '251-labelled EUF alone, and with 1,000-fold excess
EGF. After washing, cells were counted for radioactivity, and data
were analyzed by standard methods [25]. R0, EGF receptor sites per
cell; Kd, dissociation constant for EGF with its receptor. Symbols are:(•) TFB, Kd = 0.3 nM, R0 = 17,000; (•) DFB, Kd = 0.4 nss, R0 =
118,000.
50 70 130 200 200 260 280
40000
20000
10000
5000
4000
3000
2000
1000
A TEB
-a--
B DFBjI
C
IL-2
IFN TGFØ EGF IL-2
1IFN IL-2
Tk
IAlvarez et al: Fibroblast heterogeneity 19
Collageris
Fig. 6. Measurement by radioimmunoassay of secreted collagens from
fibroblasts. A total of io cells were grown to confluence and replaced
with serum-free media containing TF/I (5 g/ml), ascorbic acid (50
g/ml), and /3-aminopropionitrile (50 tg/ml) for 48 hours, after which
the supernatants were collected, and used to line the wells of polyvinyl
chloride plates for binding of adsorbed type-specific, anti-collagen
antibodies. Binding was determined by using a species-specific 1251
labelled second antibody and comparative collagen standards [251. SEM
for repetitive collagen measurements varied by 5 to 10%. Symbols are:
(U) TFB; () DFB.
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within each fibroblast population, there may be a similar or
different effect on the secretion of each of the four species of
collagens. The EGF response by TFBs in Figure 9D, for
example, demonstrates that a 2 nglml dose stimulates types III
and V, but depresses types I and IV, while in Figure 1OC the
response of DFBs to 10 U/ml of IL-i is stimulatory for type I,
but repressive for types III, IV, and V. Comparisons of collagen
secretion between TFBs and DFBs grown in various doses of
cytokine also illustrates the heterogeneity of effect which is
transcripts. J totai 01 hU p.g per iane 01 LOIU! icrit was resoiveu oy
electrophoresis in 0.8% agarose/formaldehyde gels. The gels were
blotted onto Zetabind paper and hybridized with 32P-labelled probes
(SA = 0.5 to 1.0 x l0 cpm4g) specific for collagens type I, III, IV, and
V. Probes were washed at high stringency and autoradiographed at
—70°C. Mature transcripts for each collagen were detected: a2(l)
—4700 bp; al(III) —5300 bp; cal(IV) —6500 bp; and a2(V) —5000 bp [29,
31].
cytokine and dose dependent. Such changes for the middle
cytokine dose used in each experiment are summarized in Table
1. At these doses 80% of the collagen responses to all the
cytokines in DFBs seem repressive, while only the same was
true for 35% of the responses in TFBs. Opposite effects in
collagen secretion were observed between TFBs and DFBs for
collagen types III and IV with EGF, type I with 7IFN, types I
and IV with TGFf3, types I, III and V with IL-I, and types I, IV
and V with IL-2. In all cases but one, these differences were
Fig. 8. Heterogeneity of cytokine-induced
changes in collagen secretion from TFBs and
DFBs by radioimmunoassay. Methods similar
to Figure 6 with various cytokines added at
several doses for the 48-hour incubation
interval. SENt for repetitive collagen
measurements varied by 5 to 15%.
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suppressive in DFBs and stimulatory in TFBs. These results
collectively indicate that individual cytokine interactions in
serum-free media may differentially affect collagen secretion by
a given fibroblast population, and that results amount anatom-
ically distinct fibroblasts can also be distinct from each other.
Discussion
In this report we have undertaken a comparative study of the
proliferative and biosynthetic properties of low-passage fibro-
blasts in cultures derived from the renal interstitium (TFBs) and
the dermis (DFB5) of genetically identical mice. In the early
design of these experiments we hypothesized that, since both
the dermis and the renal tubulointerstitium provide structural
surface barriers to the outside environment, their fibroblasts
might have acquired the general properties of functional simi-
larity. For a variety of reasons, some of which are demon-
strated in this paper, it seems, however, that each anatomic
compartment has evolved uniquely to produce an unambiguous
heterogeneity.
The notion of biological heterogeneity among fibroblasts
residing in anatomically distinct sites, from clones within the
same site, or from normal and diseased tissues has been
advanced from studies that previously demonstrate differences
among fibroblasts with regard to their genotype [36], pheno-
typic markers [19, 34], rate of senescence [37], glycosamino-
glycan secretion [211, responsiveness to prostanoids [38], hor-
mones [16, 20], or growth factors [9—13, 39], as well as by their
expression of glucocorticoid receptors [16], or collagen pheno-
types [171. In most reports the culture conditions, presence or
concentration of serum, and the nature of the end-point assays
have all been somewhat different. Many of these previous
studies also used donor cells from genetically diverse, outbred
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backgrounds (humans and rabbits) which makes broad extrap-
olations regarding heterogeneity somewhat problematic. In
human experimentation such issues have been circumvented
partially by focusing on experiments which evaluate clonal
heterogeneity within single tissues [14—18]. In genetically-out-
bred cell donor systems it is hard, nevertheless, to draw
comparisons between normal and diseased tissue because the
baselines may not be the same.
In our experiments we chose to examine the issue of fibro-
blast heterogeneity between different anatomic compartments
by evaluating the paracrine responsiveness of skin and tubu-
lointerstitial fibroblasts from inbred mice which we have used
previously to study autoimmune injury [401. We chose end-
point assays of cellular growth and collagen phenotype per-
formed in serum-free media with or without cytokine stimula-
tion. Although our findings support the presence of such
heterogeneity between normal anatomic compartments, they do
not address the possibility that subpopulations of fibroblasts,
already engaged in organ fibrogenesis in vivo, would demon-
strate more or less heterogeneity, or express more or less
similar phenotypic characteristics when seeded in experimental
cultures.
In serum-free conditions, cultures of our tubulointerstitial
and skin fibroblasts differed from each other in their growth
characteristics. Neither cell type proliferated very well in
response to IL-2 or yIFN. DFBs, however, proliferate better
than TFBs when co-cultured in the presence of TGF/3 and EGF.
This latter difference is not all that remarkable when one
considers that DFBs express a greater number of EGF recep-
tors. This dissimilarity, however, in EGF receptor number, but
not in affinity, did not predict differences in collagen secretion
in DFBs after stimulation with EGF. Such a curious paradox is
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Fig. 10. Measurement of cytokine-induced
changes in collagen secretion in DFBs by
radioimmunoassay. See Legends in Figures 6
and 8. Symbols are: (U) type I; (D) type III;
(0) type IV; (0) type V.IL-i, U/mi
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Table 1. Summary of the effects of mid-level cytokine conce
on the secretion of collagens
ntrations
Cytokines
Collagen secretion
I III IV V
A. TFB
EGF H t
yIFN t ft H
TGF/3 ft It
IL-I II If
IL-2 I I
B. DFB
EGF H I H I
yIFN I II I
TGF/3 H I I I I.
IL-I If I I I
IL-2 II II I
Values for collagen secretion determined from mid-dose stimulations
by cytokines [Figures 8 and 9; EGF (2 nglml), 7IFN (100 units/mI),
TGF/3 (0,2 ng/mI), IL-i (10 Units/mI), and IL-2 (10 units/mi)]. Arrows
reflect percent change from control where f = 20—50% increase; I I
= >50% increase; I = 20—50%decrease; and I I = >50% decrease.
currently unresolved, but may relate to the sensitivity or
differences in signal transduction mechanisms between prolif-
eration and collagen synthesis in fibroblasts, or to the relative
abundance of co-expressed biosynthetic inhibitors (work in
progress).
Both cell types, furthermore, demonstrate quantitative, but
not qualitative, differences in their expression of types I, III,
IV, and V collagens. It is intriguing that TFBs secrete increased
amounts of type IV collagen when compared to DFBs. This
may have evolved in an organ-specific manner because of the
juxtaposition and location of TFBs in potential spaces between
tubular epithelium resting on tubular basement membrane,
which is the only structure in the interstitium that contains type
IV collagen [41, 42; data not shown]. Also, of general interest is
the observation, at mid-level doses of cytokines, that only 35%
of potential collagen secretory responses were inhibitory in
TFBs, while 80% were inhibitory in DFBs. Perhaps dermal
fibroblasts which are a more exposed barrier in host defense
may have evolved a more conservative secretory response to
inflammation-relevant cytokines, while tubulointerstitial fibro-
blasts in a more sequestered microenvironment may not have
acquired such restraint, perhaps to the detriment of preserving
normal renal mass over the lifetime of the host [43].
Two random clones isolated from the TFB parent cell line
produced similar proliferation and collagen biosynthesis pro-
files when compared to each other, but were slightly different
than the parent line (data not shown). This latter finding points
to the potential difficulty of evaluating true heterogeneity
among TFBs. Subcloning, for example, may select for similar
cells more likely to succeed as clones rather than for phenotypic
differences. Since our clones produced a slightly different
collagen secretory profile when compared to the parent line, the
use of clones may also not always provide the most direct
evidence for the presence of heterogeneity within a normal
organ. Cultured fibroblasts obtained from tissues undergoing a
fibrogenic response, in addition, may be more heterogeneous
than those found in normal tissue [14, 44]. Products of immune-
reactive cells can also alter the function of fibroblasts [9—13],
and tubulointerstitial fibrosis, for example, is a common sequela
of infiltrating immune lymphocytes [1]. This T cell-mediated
inflammation begins focally, and it is conceivable that fibroblast
exposure to inflammatory cytokines at the epicenter of this
response produces cell subpopulations transformed function-
ally to a level of phenotypic heterogeneity that can be distin-
guished from fibroblasts in the periphery [45; work in progress].
I f TFBs in culture, for example, secrete greater amounts of
I I collagen types I and IV in the presence of low concentrations of
1 TGFI3, IL-2, and EGF, while higher concentrations are inhibi-
tory. DFBs also produce decreased amount of all collagens in
the presence of TGF/3 and increases in types I and III in the
presence of yIFN. These latter findings, while not predicted
necessarily from previous measurements made with more con-
ventional or more widely used cell lines, nevertheless empha-
sizes the potential heterogeneity of organ-based primary cul-
tures. There also is a developing literature that suggests that
cytokines like TGFI3 may affect collagen synthesis depending
on the involved cell type [46, 47], whether the cells are grown in
2-D or 3-D cultures [48], and depending on what kind of matrix
they are passaged [49]. In the current study we stimulated all
cells using the same culture conditions in order to focus on
differences based potentially on site of origin.
In summary, our experiments indicate some of the challenges
faced in any effort to generalize regarding the growth charac-
teristics, or secretory activity of all fibroblasts, when studies
are performed on cells derived from only one anatomic com-
partment. The biologic forces of organ differentiation likely
impose unique capacities on indigenous cells. Such develop-
mental control may ultimately influence or provide a novel
character to the local structural response to tissue repair.
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